Skip to content

Clinical trials

Phase 3 Recurrence trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 3 Country / region: Norway Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20091
20101
20121
20151
20162
20172
20192
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting3
Recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Celgene3
AbbVie2
Asker & Baerum Hospital1
AstraZeneca1
Bristol-Myers Squibb1
Genmab1
GlaxoSmithKline1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Nordic Myeloma Study Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence18
Multiple Myeloma8
Neoplasms5
Atrial Fibrillation1
Breast Neoplasms1
Endometrial Neoplasms1
Epilepsy1
Headache1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.